Inventor and CEO
Over 25 years’ experience as team member, leader and manager in the development of medical systems (Biosense Webster, EPD Medical), industrial systems (Scitex, Creo, InkSure), and military systems (Elop). Inventor and co-inventor of over 20 patents in optics, mechanics and electronics. BSc Electronic Engineering, Tel Aviv University; MBA, Bar-Ilan University.
CEO & Managing Partner at NGT3 VC, Board Member
CFO and Board Member at NGT3 VC
Former CEO and director of Beta-O2 Technologies. Served as CEO of the Technion Entrepreneurial Incubator. Led establishment of and investment in more than 50 companies, including: Prolor Biotech (sold to OPKO, NYSE: OPK), Mazor Robotics (NASDAQ: MZOR), ReWalk (NASDAQ: RWLK), Corindus (NASDAQ: CVRS), Regentis and many others.
CFO of over 30 start-up companies since joining NGT3 in 2006, Nizar has hands-on financial management experience at all levels: from seed investment through early and late financial rounds.
Director of Strategy
Entrepreneur, inventor and medical device industry executive for past 20 years, having in-depth experience in managing and creating value for medical device companies. Specialized in developing and introducing a wide range of medical technologies to market, strategic planning, strategic collaborating and M&A’s.
In 2009 David established Stimatix GI and serves as its CEO. In 2014, Stimatix assets were acquired by B.Braun. Prior to Stimatix David served as V.P. of R&D Vision Sciences Inc., a N.Y.-based medical device company specializing in flexible endoscopy. Prior to Vision Sciences Inc. he served as COO and R&D leader at CByond (Olympus-Gyrus-ACMI subsidiary) specializing in minimal invasive surgery.
To date, David published 23 patents applications of which 18 been granted.
David holds an MBA from Haifa University and a B.Sc. electrical engineering from Ben-Gurion University of the Negev (honors).
Livnat Ben Zur
Chief Business and Technology Officer of NGT3 VC
Ms. Ben-Zur brings over 20 years of experience in the medical device and healthcare industries, holding executive positions in management, business and marketing, and fundraising in the United States and in Israel.
Prior to joining NGT, Livnat was the CEO of Corolabs, a deep-lung inhaled therapies, and prior to that the General Manager of Regentis Biomaterials, a tissue regeneration company.
Livnat served as VP Business Development & Director of Women’s Health Program at Galil Medical, where she spearheaded product development processes related to the breast and gynecology applications, as well as managed the clinical program of these applications. Before that Ms. Ben-Zur served as a Director of Marketing of Medinol Ltd, and as Business director of Medical Technology group of Datamonitor Inc.
She holds MBA in marketing and International Business from Tel Aviv University and Bachelor of Sciences, in Biology from Tel Aviv University.
Operation and Production Manager
Operation and manufacturing manager
10-year experience in medical start-up companies (Stimatix GI, MHD, Vessi Medical), in product management, development, and related research, from inception stage to market deployment.
Extensive know-how and hands-on experience in medical devices: technologies, manufacturing, and supply chain.
Contributor to several medical devices currently in the global market.
Co-Inventor of 5 registered patents.